The global home medical equipment consumption pattern will depend on demographic and epidemiological development. Increased efforts in the fight against chronic illnesses such as respiratory diseases, kidney disorders, and cancer will boost the demand for home therapeutic devices. Products such as portable oxygen concentrators, continuous positive airway products, ventilators, and other accessories will undergo the fastest growth in sales in this market. Increasing numbers of baby boomers and an increase in the population of aged people on a global scale will also assist in the growth of this market.

Development in the convenience in handling and usage of these equipments due to the increase in chronically ill patients will create a rapid increase in demand. The home IV devices segment will also experience upward growth as intense control in outpatient visits and shorter hospital stays will lead to an increase in the number of cancer and other chronic disease patients to be administered parenteral nutrition, and other therapeutic modalities at home.

It is estimated that the U.S. will be the largest market for home medical equipments owing to its wide base of home healthcare equipment providers, good reimbursement policies, better healthcare infrastructure and high healthcare expenditure. Moreover, the recent changes in the healthcare industry due to ‘Obamacare’ will also boost the demand for such equipment, since almost 30 million uninsured Americans will now enjoy medical coverage.

Emerging economies such as the BRIC countries will be the fastest growing market for such products as the economic condition of such countries is rapidly improving. On the other hand, the already developed markets of Europe, Canada, Japan, Australia, and South Korea will show fair demand for therapeutic, monitoring, and support products as the sales levels in these markets will rise.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

North America 

Asia Pacific 

Europe

Rest of the World  

This report provides comprehensive analysis of 

Market growth drivers 

Factors limiting market growth

Current market trends 

Market structure

Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

» Read More...

The generic drugs industry comprises of the manufacture and marketing of certain drugs which have the same active ingredients as the brand-name drugs manufactured by any pharmaceutical company. The major benefit of generic drugs is that the cost of such drugs is much less than that of branded drugs. Generic drugs come under the same governing framework as that of the brand-name drugs. The rationale behind generic drugs is that the patented drugs generally have a patent life of 20 years. However, the patent life of such drugs begins from the clinical trials and thus their commercial life is far less (approximately 15 years). After the patent expiry the manufacturers of such drugs face intense pricing pressure because of the competition from their cheap generic counterparts.

Sale of generic drugs also holds importance for entities such as wholesalers, pharmacies, and pharmacy benefit managers, as the sale of generic drugs provides higher profit margins than the sale of branded drugs. The generic drugs market is classified as simple generics, super-generics and biosimilars. Furthermore, the generic drugs market can be classified on the basis of their therapeutic applications such as anti-infective drugs, central nervous system drugs, cardiovascular products, anti-arthritis drugs, respiratory products, anti-cancer drugs and others. 

Geographically, North America is the largest consumer and manufacturer of generic drugs. In addition, the highest growth in this market is observed in Asia-Pacific. 

Some of the major generic drugs manufacturers include pharmaceutical companies such as Dr. Reddy’s Laboratories, Actavis, Mylan, Inc., Apotex, Inc., Ranbaxy Laboratories, Ltd, Hospira, Inc., Par Pharmaceutical, Inc., Sandoz International GmbH, Teva Pharmaceutical Industries, Ltd., Watson Pharmaceuticals, Ltd. and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

North America 

Asia Pacific 

Europe

Rest of the World  

This report provides comprehensive analysis of 

Market growth drivers 

Factors limiting market growth

Current market trends 

Market structure

Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

» Read More...

An intelligent and secured network provides security, flexibility, robustness and personalized solutions to the users.  It is used to curb web attacks, windows exploits, network attacks etc. These networks help prevent frauds, information leakage and also help increase security and performance of devices. Some of the drivers pushing the growth of these networks include rise in hacktivism, increasing anonymous proxies, growth in IT organizations etc. One of the restraints which may limit the growth is the high installation and configuration costs of networks. 

There are many opportunities for the intelligent and secure networks such as in electricity networks, military networks and many others. U.S., Europe and NATO members have signed an agreement to deploy and upgrade standards of encrypted networks across the defense and military systems of the member countries.

Intelligent and secured networks use following physical entities: SSP(Service Switching Point), NAP(Network Access Point), SCP(Service Control Point), AD(Adjunct), IP, SN(Service Node), SSCP(Service Switching and Control Point), SDP, SMP(Service Management Point), SCEP(Service Creation Environment Point), SMAP(Service Management Access Point)

Some of the major players in this space include Alcatel-Lucent, Thales, Huawei, EADS, Fujitsu, British Telecom plc, Siemens AG, Nokia Telecommunications OY, Helsinki Telephone Company, Telenor, Cable & Wireless Communications plc, Nortel Europe etc.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

North America 

Asia Pacific 

Europe

Rest of the World  

This report provides comprehensive analysis of 

Market growth drivers 

Factors limiting market growth

Current market trends 

Market structure

Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

» Read More...

Touch screen technology acts as an interface between users and computers which provide an easy visual experience to the users. The popularity of touch screen technology in smartphones, tablets, PCs, mobile phones, and in many other information devices is gaining momentum. Touch screen technology provides hassle free interactivity and strong control on the device. There are various types of touch screen available in the market such as resistive touchscreen, capacitive touchs creen, surface acoustic wave, optical touchscreen, and infrared. 

The touchscreen market is driven by factors such as increased consumer spending on mobile 

devices, rapid popularization, easy accessibility, and increasing ergonomics. The touchscreen applications market is segmented into sectors such as self checkout counters, PDAs, tablet PCs, hand held gaming consoles, ATMs, airport check-ins, mobile phones, automotives, and many more.

Some of the major players in this space are 3M, Acer, AMT, Apple, AT&T ,Atmel AU, Optonics, Balda, Bridgestone, BYD, Cypress, Displax, E Ink, Fujitsu, Giant Plus, Google, HannStar, Huawei, InnoLux, Intel, IRTouch, LG, Liquavista, Neonode,  Nokia, Sony, Sony Ericsson, Sharp, Qualcomm, Hitachi, Freescale Gigabyte, HP, Motorola, Samsung, Microsoft, Broadcom, Avago, Dell, HTC, Input Dynamics,  Lenovo etc

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

North America 

Asia Pacific 

Europe

Rest of the World  

This report provides comprehensive analysis of 

Market growth drivers 

Factors limiting market growth

Current market trends 

Market structure

Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

» Read More...

Depression is considered as one of the most common forms of psychiatric disorders. Depression is a disabling condition that not only affects the health and wellbeing of the patient but also adversely affects the family. Every year the prevalence of depression is rapidly increasing across the world. Anxiety is a reaction to stress. Normally, it is characterized as an urge to deal with adverse situations. However, extreme levels of anxiety may be called anxiety disorder. This disorder is characterized on the basis of the behavior of the individual. The major forms of anxiety disorders include obsessive-compulsive disorder, phobias, post-traumatic stress disorder, and panic disorder.

The causes of both the above disorders are not comprehensively established. The several causes of depression and anxiety disorders include lower level of some neurotransmitters, genetic inheritance, psychological reasons, emotional upheavals, and also due to environmental, spiritual, and social factors. There is no uniform pattern of treatment for patients suffering with depression or anxiety disorders. Any treatment that works on one patient may not be as effective on another.

Thus the treatments for depression and anxiety disorders are customized. Out of the various modes of therapies available for depression, psychotherapy is the most common. Psychodynamic therapy, behavioral therapy, and interpersonal therapy are the major types of psychotherapies used for treating depression. The various medications used in treatment for depression are selective serotonin reuptake inhibitors, dual-action antidepressants, atypical antidepressants, mood stabilizers and anticonvulsants, tricyclic antidepressants, and monoamine oxidase inhibitors.

In addition, medications for anxiety are found to be substantially helpful in treating patients with anxiety disorders whose daily function is being disturbed due to the illness. The medications that are often used for treating anxiety disorders are benzodiazepines and antidepressants. Furthermore, in some cases, electroconvulsive therapy is also found to be useful in severe cases. In addition to the above therapeutic methods, lifestyle changes are also prescribed to the patients. The other less often and/or auxiliary methods of treating depression and anxiety disorders are music therapy, botanical medicines, mind-body practice, naturopathic medicine, and homeopathy.

The major antidepressants and anti-anxiety drug manufacturers include pharmaceutical companies such as AstraZeneca, Eli Lilly and Company, Johnson and Johnson, Pfizer, Inc., Sanofi-Aventis, Merck and Company, Inc., GlaxoSmithKline, and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

North America 

Asia Pacific 

Europe

Rest of the World  

This report provides comprehensive analysis of 

Market growth drivers 

Factors limiting market growth

Current market trends 

Market structure

Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

» Read More...